Literature DB >> 11476548

A spectrophotometric assay for quantitative determination of kcat of herpes simplex virus type 1 thymidine kinase substrates.

P Schelling1, G Folkers, L Scapozza.   

Abstract

A simple method to determine the in vitro catalytic turnover constant of several substrates of herpes simplex virus type 1 thymidine kinase is presented in this study. The method is based on a continuous spectroscopic enzyme-coupled assay and allows one to monitor the herpes simplex virus type 1 thymidine kinase activity in the presence of unlabeled substrates. A clear correlation between the catalytic turnover constant and the rate of decrease in absorbance over time during the assay has been demonstrated. Exploiting this correlation, this method has been used to determine rapidly and precisely the catalytic turnover constant of antiviral lead compounds not readily available in the radioactive labeled form. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476548     DOI: 10.1006/abio.2001.5191

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Quaternary structure change as a mechanism for the regulation of thymidine kinase 1-like enzymes.

Authors:  Dario Segura-Peña; Joseph Lichter; Manuela Trani; Manfred Konrad; Arnon Lavie; Stefan Lutz
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

2.  Systematic exploration of active site mutations on human deoxycytidine kinase substrate specificity.

Authors:  Pinar Iyidogan; Stefan Lutz
Journal:  Biochemistry       Date:  2008-03-25       Impact factor: 3.162

3.  Prodrug activation by Cryptosporidium thymidine kinase.

Authors:  Xin E Sun; Lisa Sharling; Mani Muthalagi; Devaraja G Mudeppa; Krzysztof W Pankiewicz; Krzysztof Felczak; Pradipsinh K Rathod; Jan Mead; Boris Striepen; Lizbeth Hedstrom
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

4.  Binding of ATP to TK1-like enzymes is associated with a conformational change in the quaternary structure.

Authors:  Dario Segura-Peña; Stefan Lutz; Christian Monnerjahn; Manfred Konrad; Arnon Lavie
Journal:  J Mol Biol       Date:  2007-03-15       Impact factor: 5.469

5.  Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.

Authors:  Mark N Prichard; Kathy A Keith; Mary P Johnson; Emma A Harden; Alexis McBrayer; Ming Luo; Shihong Qiu; Debasish Chattopadhyay; Xuesen Fan; Paul F Torrence; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

6.  Quantitative Detection of Nucleoside Analogues by Multi-enzyme Biosensors using Time-Resolved Kinetic Measurements.

Authors:  Pravin Muthu; Stefan Lutz
Journal:  ChemMedChem       Date:  2016-03-02       Impact factor: 3.466

7.  Structural and Kinetic Characterization of Thymidine Kinase from Leishmania major.

Authors:  Jennifer Timm; Cristina Bosch-Navarrete; Eliseo Recio; Joanne E Nettleship; Heather Rada; Dolores González-Pacanowska; Keith S Wilson
Journal:  PLoS Negl Trop Dis       Date:  2015-05-15

8.  Biochemical Characterizations of Human TMPK Mutations Identified in Patients with Severe Microcephaly: Single Amino Acid Substitutions Impair Dimerization and Abolish Their Catalytic Activity.

Authors:  Junmei Hu Frisk; Jo M Vanoevelen; Jörgen Bierau; Gunnar Pejler; Staffan Eriksson; Liya Wang
Journal:  ACS Omega       Date:  2021-12-06

9.  Naphthoquinone derivatives exert their antitrypanosomal activity via a multi-target mechanism.

Authors:  Simone Pieretti; Jurgen R Haanstra; Muriel Mazet; Remo Perozzo; Christian Bergamini; Federica Prati; Romana Fato; Giorgio Lenaz; Giovanni Capranico; Reto Brun; Barbara M Bakker; Paul A M Michels; Leonardo Scapozza; Maria Laura Bolognesi; Andrea Cavalli
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

10.  Accelerated discovery via a whole-cell model.

Authors:  Jayodita C Sanghvi; Sergi Regot; Silvia Carrasco; Jonathan R Karr; Miriam V Gutschow; Benjamin Bolival; Markus W Covert
Journal:  Nat Methods       Date:  2013-11-03       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.